The move follows AstraZeneca’s previously announced plan to complete a direct listing of its Ordinary Shares and debt securities on the New York Stock Exchange
Through this acquisition Merck has added Ohtuvayre (ensifentrine) to its growing cardio-pulmonary pipeline and portfolio
Shares and American Depositary Shares of Olink for $26.00 per Share
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
Completion of the demerger of Haleon and share consolidation of GSK
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Subscribe To Our Newsletter & Stay Updated
